Additional mechanistic studies demonstrated decursin’s capacity to suppress gastric cancer progression via CXCR7/STAT3/c-Myc signaling pathway inhibition and caspase-3-dependent apoptosis induction [15]. The gene discussed is MYC; the disease is gastric cancer.